27737807|t|Cognitive assessment of pycnogenol therapy following traumatic brain injury
27737807|a|We have previously shown that pycnogenol (PYC) increases antioxidants, decreases oxidative stress, suppresses neuroinflammation and enhances synaptic plasticity following traumatic brain injury (TBI). Here, we investigate the effects of PYC on cognitive function following a controlled cortical impact (CCI). Adult Sprague-Dawley rats received a CCI injury followed by an intraperitoneal injection of PYC (50 or 100mg/kg). Seven days post trauma, subjects were evaluated in a Morris water maze (MWM) and evaluated for changes in lesion volume. Some animals were evaluated at 48h for hippocampal Fluoro-jade B (FJB) staining. The highest dose of PYC therapy significantly reduced lesion volume, with no improvement in MWM compared to vehicle controls. PYC failed to reduce the total number of FJB positive neurons in the hippocampus. These results suggest that the reduction of oxidative stress and neuroinflammation are not the key components of the secondary injury that contribute to cognitive deficits following TBI.
27737807	0	20	Cognitive assessment	T060	C0870300
27737807	24	34	pycnogenol	T109,T121	C0072642
27737807	35	42	therapy	T061	C0087111
27737807	53	75	traumatic brain injury	T037	C0876926
27737807	106	116	pycnogenol	T109,T121	C0072642
27737807	118	121	PYC	T109,T121	C0072642
27737807	123	132	increases	T081	C0205217
27737807	133	145	antioxidants	T121	C0003402
27737807	147	156	decreases	T081	C0205216
27737807	157	173	oxidative stress	T049	C0242606
27737807	175	185	suppresses	T169	C1260953
27737807	186	203	neuroinflammation	T046	C1408627
27737807	208	236	enhances synaptic plasticity	T042	C1622185
27737807	247	269	traumatic brain injury	T037	C0876926
27737807	271	274	TBI	T037	C0876926
27737807	286	297	investigate	T169	C1292732
27737807	302	312	effects of	T080	C1704420
27737807	313	316	PYC	T109,T121	C0072642
27737807	320	338	cognitive function	T041	C0392335
27737807	351	377	controlled cortical impact	T169	C0443254
27737807	379	382	CCI	T169	C0443254
27737807	385	390	Adult	T100	C0001675
27737807	391	410	Sprague-Dawley rats	T015	C0034715
27737807	422	432	CCI injury	T037	C3263723
27737807	448	473	intraperitoneal injection	T061	C0021493
27737807	477	480	PYC	T109,T121	C0072642
27737807	499	509	Seven days	T079	C1254367
27737807	510	521	post trauma	T033	C0150062
27737807	523	531	subjects	T098	C0080105
27737807	537	546	evaluated	T058	C0220825
27737807	552	569	Morris water maze	T059	C0022885
27737807	571	574	MWM	T059	C0022885
27737807	580	589	evaluated	T058	C0220825
27737807	605	618	lesion volume	T033	C0243095
27737807	625	632	animals	T008	C0003062
27737807	638	647	evaluated	T058	C0220825
27737807	659	670	hippocampal	T029	C3496509
27737807	671	684	Fluoro-jade B	T109,T130	C3661365
27737807	686	689	FJB	T109,T130	C3661365
27737807	691	699	staining	T059	C0487602
27737807	713	717	dose	T081	C0178602
27737807	721	724	PYC	T109,T121	C0072642
27737807	725	732	therapy	T061	C0087111
27737807	733	754	significantly reduced	T080	C0392756
27737807	755	768	lesion volume	T033	C0243095
27737807	775	789	no improvement	T033	C3844714
27737807	793	796	MWM	T059	C0022885
27737807	809	825	vehicle controls	T096	C0009932
27737807	827	830	PYC	T109,T121	C0072642
27737807	831	837	failed	T169	C0231175
27737807	841	847	reduce	T080	C0392756
27737807	868	871	FJB	T109,T130	C3661365
27737807	881	888	neurons	T025	C0027882
27737807	896	907	hippocampus	T023	C0019564
27737807	915	922	results	T034	C0456984
27737807	923	930	suggest	T078	C1705535
27737807	940	949	reduction	T061	C0441610
27737807	953	969	oxidative stress	T049	C0242606
27737807	974	991	neuroinflammation	T046	C1408627
27737807	1004	1018	key components	T077	C1705248
27737807	1026	1042	secondary injury	T037	C3263722
27737807	1048	1058	contribute	T052	C1880177
27737807	1062	1080	cognitive deficits	T033	C2237374
27737807	1091	1094	TBI	T037	C0876926